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IMMUNIZATIONS
 CDC's Health Alert Network publishes an advisory
urging rapid
antiviral treatment of very ill and
high-risk suspect influenza patients without waiting for
testing
 Clear Recommendations on Vaccination Are Important
to Your Patients
ADVERSE EFFECTS
 Antidepressant Effexor Linked to Postpartum
Bleeding in Study
Pharmacist Education
 4 GERD Counseling Points for Pharmacists
 In the Clinic: Metformin and Pancreatic Cancer
NEWS
 5 Tips for Traveling to the U.S. With Medications
 Another STD Spurs Concern
o British study concludes Mycoplasma
genitalium infection is transmitted through
sexual contact
 Greenstone launches Detrol LA authorized generic
 Encapsulated cells treat diabetes in mice
 Prepublication standards: check out Opioid Treatment
Programs update, effective July 1
 Painkillers Don't Ease Disability Due to Nerve Damage:
Study
 ASTHMA
o Report Calls for New COPD, Asthma
Treatment Methods
01/26/2016 ·Baxter


















01/16/2016 ·Abbott's ·Sterile Compounded Products that ·Lack of Sterility ·Abbott's
RECALLS
 0.9% Sodium Chloride Injection,
Metronidazole Injection, and Clinimix E 5/15
 Licorice Coughing Liquid - Contains undeclared
morphine




 MedWatch: The FDA Safety Information and Adverse
Event Reporting Program
 January 2016 Drug Safety Labeling Changes
 Central Venous Catheters and Pressure Monitoring Sets
 Syrspend SF and Syrspend SF Grape Suspending Agents
by
Fagron: FDA Alert - Microbial Contamination
 Oxylog 2000 Plus, 3000, and 3000 Plus Emergency
Transport Ventilators by Dräger Medical: Class I Recall
FDA approvals
 Aurobindo’s generic Vfend
 Two Sumatriptan Treatments for Migraine
FDA Enforcement Report
 Lyrica (pregabalin) capsules, 75 mg, 90-count bottle,
 Nystatin, USP Powder for Rx compounding, 50 Million
Units,
 Nystatin, USP Powder for Rx compounding, 150 Million
Units,
 Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx
only,
INSURANCE
 Oklahoma Health Care Authority
o Prior Authorization of Medications Used to
Treat Breast Cancer
o Yearly Compliance with the Deficit Reduction
Act of 2005
o Non-Invasive Prenatal Testing
o Controlled Substance Monitoring and Drugs of
Abuse Testing










Valsartan and Hydrochlorothiazide Tablet, Film Coated (Discontinuation)
 Valsartan Tablets (Discontinuation)
·February 12, 2016
 Memantine Hydrochloride (Namenda) Unit Dose XR Capsules (Discontinuation)
·February 05, 2016
 Sodium Bicarbonate Injection, USP (Currently in Shortage)
·February 04, 2016
 Sodium Bicarbonate Injection, USP (Currently in Shortage)
·February 03, 2016
 Potassium Acetate Injection, USP (Currently in Shortage)
 Sodium Acetate Injection, USP (Currently in Shortage)
·Updated
·February 16, 2016
 Azathioprine Tablet (Resolved)
·February 12, 2016
 Levetiracetam (Keppra) Injection (Resolved)
·February 11, 2016
 Memantine Hydrochloride (Namenda) XR Capsules (Resolved)
·February 10, 2016
 Cefepime Injection (Currently in Shortage)
 Imipenem and Cilastatin for Injection, USP (Currently in Shortage)
 Meropenem for Injection, USP (Currently in Shortage)
 Potassium Chloride Injection (Currently in Shortage)
·February 08, 2016
 Desmopressin Acetate Injection (Currently in Shortage)
MedWatch: The FDA Safety Information and Adverse Event Reporting Program
·January 2016 Drug Safety Labeling Changes includes 26 products with revisions to Prescribing
Information. Posted 02/12/2015
·Central Venous Catheters and Pressure Monitoring Sets and Trays by Cook Medical: Recall - Catheter
Tip Fracture and/or Separation Risk of stroke, kidney injury, or damage to the intestines or limbs. Posted
02/11/2016
·Syrspend SF and Syrspend SF Grape Suspending Agents by Fagron: FDA Alert - Microbial Contamination
with Yeast If an immunocompromised patient or a child with an immature immune system ingests the
contaminated product, there is a potential the patient will get an infection for which systemic
antimicrobial therapy would be necessary. Posted 02/10/2016
·Oxylog 2000 Plus, 3000, and 3000 Plus Emergency Transport Ventilators by Dräger Medical: Class I
Recall - System Error May Lead to a Halt in Ventilation Therapy If the device operator does not
intervene, the patient may not receive enough oxygen and could suffer serious adverse health
consequences, including injury or death. Posted 02/10/2016
FDA approves Aurobindo’s generic Vfend
·http://www.drugstorenews.com/article/fda-approves-aurobindos-generic-vfend
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INSURANCE·Oklahoma Health Care Authority
·2016-04 ·Prior Authorization of Medications Used to Treat Breast Cancer ·2/3/2016
·2016-03 ·Yearly Compliance with the Deficit Reduction Act of 2005 ·1/28/2016
·2016-02 ·Non-Invasive Prenatal Testing ·1/6/2016
·2016-01 ·Controlled Substance Monitoring and Drugs of Abuse Testing ·1/5/2016




·CDC's Health Alert Network publishes an advisory urging rapid antiviral treatment of very ill and high-
risk suspect influenza patients without waiting for testing
o http://www.immunize.org/express/issue1227.asp




·Antidepressant Effexor Linked to Postpartum Bleeding in Study
o https://www.nlm.nih.gov/medlineplus/news/fullstory_157231.html
oPharmacist Education








·5 Tips for Traveling to the U.S. With Medications
o http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm484154.htm
·Another STD Spurs Concern
o British study concludes Mycoplasma genitalium infection is transmitted through sexual contact
o https://www.nlm.nih.gov/medlineplus/news/fullstory_157233.html






·Encapsulated cells treat diabetes in mice
o http://www.nih.gov/news-events/nih-research-matters/encapsulated-cells-treat-diabetes-mice




·Painkillers Don't Ease Disability Due to Nerve Damage: Study
o https://www.nlm.nih.gov/medlineplus/news/fullstory_157017.html
ASTHMA
·Report Calls for New COPD, Asthma Treatment Methods
o http://www.consultant360.com/exclusives/new-treatment-needed-copd-asthma-patients
